Telix Pharmaceuticals Limited Stock
Stocks
TLX
AU000000TLX2
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 14.72 AUD | +2.15% |
|
+1.73% | +31.43% |
| Market Cap | 5B 3.53B 3.06B 2.85B 2.62B 4.95B 336B 33.48B 13.14B 168B 13.25B 12.96B 556B | P/E 2026 * |
213x | P/E 2027 * | 90.8x |
|---|---|---|---|---|---|
| Enterprise Value | 5.41B 3.82B 3.31B 3.08B 2.84B 5.35B 363B 36.22B 14.22B 182B 14.34B 14.02B 602B | EV / Sales 2026 * |
3.85x | EV / Sales 2027 * | 3.37x |
| Free-Float |
83.35% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Telix Pharmaceuticals Limited
| 1 day | +2.15% | ||
| 1 week | +1.73% | ||
| Current month | +3.59% | ||
| 1 month | -12.80% | ||
| 3 months | -5.64% | ||
| 6 months | +45.45% | ||
| Current year | +31.43% |
| 1 week | 13.95 |  | 14.91 |
| 1 month | 13.95 | | 17.76 |
| Current year | 8.26 | | 17.76 |
| 1 year | 8.26 | | 19.35 |
| 3 years | 8.2 | | 31.97 |
| 5 years | 3.55 | | 31.97 |
| 10 years | 0.46 | | 31.97 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 51 | 03/01/2017 | |
Darren Smith
DFI | Director of Finance/CFO | 61 | 31/07/2022 |
| Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 51 | 03/01/2017 | |
Mark Nelson
CHM | Chairman | 66 | 03/02/2026 |
Jann Skinner
BRD | Director/Board Member | 68 | 19/06/2018 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 06/11/25 | Fiscal year | Founder | 100,708 | 0.0298% | ||
| 17/06/25 | Free | Founder | 2,595 | 0.0008% | ||
| 17/06/25 | Free | Founder | 166,483 | 0.0494% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.15% | +1.73% | -27.27% | +38.22% | 3.44B | |
| +0.90% | -2.33% | +0.68% | +14.52% | 48B | |
| +1.96% | +8.57% | +411.64% | +562.69% | 41.13B | |
| +3.83% | -4.22% | +28.91% | +8.12% | 37.56B | |
| +2.08% | +0.87% | +7.43% | +76.02% | 35.91B | |
| +2.42% | +7.27% | +14.90% | +44.79% | 29.86B | |
| +0.33% | -2.67% | - | - | 16.12B | |
| +1.11% | -0.38% | +33.56% | +123.79% | 16.05B | |
| +1.25% | +1.52% | +4.62% | +18.66% | 13.76B | |
| +4.65% | -7.92% | -1.15% | -34.78% | 12.1B | |
| Average | +2.02% | -1.97% | +52.59% | +94.67% | 25.39B | |
| Weighted average by Cap. | +1.95% | -1.28% | +80.97% | +126.85% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.41B 992M 859M 801M 737M 1.39B 94.33B 9.41B 3.69B 47.2B 3.73B 3.64B 156B | 1.62B 1.14B 990M 923M 849M 1.6B 109B 10.85B 4.26B 54.41B 4.29B 4.2B 180B |
| Net income | 16.84M 11.88M 10.29M 9.59M 8.82M 16.65M 1.13B 113M 44.23M 565M 44.61M 43.63M 1.87B | 41.97M 29.61M 25.64M 23.9M 21.99M 41.51M 2.82B 281M 110M 1.41B 111M 109M 4.67B |
| Net Debt | 410M 289M 251M 234M 215M 406M 27.52B 2.75B 1.08B 13.77B 1.09B 1.06B 45.6B | 469M 331M 286M 267M 246M 464M 31.44B 3.14B 1.23B 15.73B 1.24B 1.21B 52.11B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 05/08/26 | A$14.72 | +2.15% | 1,157,576 |
| 04/08/26 | A$14.41 | +0.91% | 1,239,098 |
| 03/08/26 | A$14.28 | +0.49% | 1,024,452 |
| 31/07/26 | A$14.21 | +1.00% | 883,833 |
| 30/07/26 | A$14.07 | -2.97% | 1,267,484 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- TLX Stock
Select your edition
All financial news and data tailored to specific country editions
